Theriva Biologics, Inc.
TOVX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000894158
No open-market purchases or sales by Theriva Biologics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $495.5K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Theriva Biologics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −3 vs. Q2 2024
- Shares held
- 492.2K
- −704.8K (−58.9%) vs. Q2 2024
- Total value
- $678.6K
- +$395.7K (+139.9%) vs. Q2 2024
- New holders
- 8
- 4 more added
- Sold out
- 11
- 6 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TOVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $495.5K |
| Q1 2026 | 22 | $385.4K |
| Q4 2025 | 21 | $272.4K |
| Q3 2025 | 20 | $177.0K |
| Q2 2025 | 17 | $126.3K |
| Q1 2025 | 11 | $209.8K |
| Q4 2024 | 10 | $60.3K |
| Q3 2024 | 18 | $678.6K |
| Q2 2024 | 22 | $327.6K |
| Q1 2024 | 24 | $366.3K |
| Q4 2023 | 24 | $452.3K |
| Q3 2023 | 21 | $572.8K |
| Q2 2023 | 18 | $1.01M |
| Q1 2023 | 19 | $724.6K |
| Q4 2022 | 22 | $477.1K |
| Q3 2022 | 26 | $1.15M |
| Q2 2022 | 33 | $2.51M |
| Q1 2022 | 35 | $3.17M |
| Q4 2021 | 35 | $3.24M |
| Q3 2021 | 36 | $3.32M |
| Q2 2021 | 31 | $3.91M |
| Q1 2021 | 32 | $5.80M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Theriva Biologics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Heights Capital Management, Inc | 141,958 | $195.9K | 0.15% | +141,958 | New |
| Anson Funds Management LP | 139,046 | $191.9K | 0.03% | +139,046 | New |
| Armistice Capital, LLC | 100,000 | $138.0K | 0.00% | +100,000 | New |
| MSD Partners, L.P. | 27,316 | $37.7K | 0.02% | −571,095−95.4% | Reduced |
| Morgan Stanley | 20,200 | $27.9K | 0.00% | +20,185+134,566.7% | Added |
| UBS Group AG | 17,851 | $24.6K | 0.00% | +17,848+594,933.3% | Added |
| Two Sigma Investments, LP | 13,566 | $18.7K | 0.00% | +13,566 | New |
| HRT Financial LP | 11,806 | $16.0K | 0.00% | +11,806 | New |
| Two Sigma Securities, LLC | 10,120 | $14.0K | 0.00% | −50,903−83.4% | Reduced |
| BlackRock, Inc. | 7,568 | $10.4K | 0.00% | +7,568 | New |
| Advisor Group Holdings, Inc. | 1,294 | $1.78K | 0.00% | −9,753−88.3% | Reduced |
| Tower Research Capital LLC (TRC) | 661 | $912 | 0.00% | +516+355.9% | Added |
| Barclays PLC | 495 | $683 | 0.00% | +495 | New |
| IFP Advisors, Inc | 307 | $58 | 0.00% | +11+3.7% | Added |
| Iron Horse Wealth Management, LLC | 14 | $19 | 0.00% | −351−96.2% | Reduced |
| Bank of America Corp | 9 | $12 | 0.00% | −137−93.8% | Reduced |
| Planning Capital Management Corp | 4 | $6 | 0.00% | −106−96.4% | Reduced |
| Danske Bank A/S | 1 | $1 | 0.00% | +1 | New |
| Vanguard Group Inc | 0 | $0 | 0.00% | −194,494−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −141,168−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −103,710−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −48,691−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −26,477−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −10,153−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Old Point Trust & Financial Services N A | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |